GMS Ventures & Investments - 17 Jan 2025 SCHEDULE 13D/A Report for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK)

Filing Manager: GMS Ventures & Investments
Reporting Manager: GMS VENTURES & INVESTMENTS
Security: Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol: OTLK
Shares outstanding: 33M shares
Disclosed Ownership: 12.7M shares
Ownership: 38.6%
Form type: SCHEDULE 13D/A
Date filed: 22 Jan 2025, 16:17
Date of event: 17 Jan 2025
Next filing: 12 Mar 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GMS VENTURES & INVESTMENTS	38.6%	12.7M	0	12.7M	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon	0001804598
SUKHTIAN GHIATH M.	38.6%	12.7M	0	12.7M	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon	0001717441